Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Marika Mende"'
Autor:
Sebastian Stasik, Marika Mende, Caroline Schuster, Sandra Mahler, Daniela Aust, Andrea Tannapfel, Anke Reinacher-Schick, Gustavo Baretton, Claudia Krippendorf, Martin Bornhäuser, Gerhard Ehninger, Gunnar Folprecht, Christian Thiede
Publikováno v:
Frontiers in Genetics, Vol 12 (2022)
The detection of plasma cell–free tumor DNA (ctDNA) is prognostic in colorectal cancer (CRC) and has potential for early prediction of disease recurrence. In clinical routine, ctDNA-based diagnostics are limited by the low concentration of ctDNA an
Externí odkaz:
https://doaj.org/article/cfe66e4dea3d4dd591e8825d0aa8db00
Autor:
Sebastian, Stasik, Marika, Mende, Caroline, Schuster, Sandra, Mahler, Daniela, Aust, Andrea, Tannapfel, Anke, Reinacher-Schick, Gustavo, Baretton, Claudia, Krippendorf, Martin, Bornhäuser, Gerhard, Ehninger, Gunnar, Folprecht, Christian, Thiede
Publikováno v:
Frontiers in Genetics
The detection of plasma cell–free tumor DNA (ctDNA) is prognostic in colorectal cancer (CRC) and has potential for early prediction of disease recurrence. In clinical routine, ctDNA-based diagnostics are limited by the low concentration of ctDNA an
Autor:
Christian Thiede, C. Röllig, Christine Borkmann, Claudia D. Baldus, Ulrich Dührsen, Gerhard Ehninger, Marika Mende, Gesine Bug, Lars Fransecky, Matthias Stelljes, Richard Noppeney, Antje Schubert, Johannes Schetelig, Katharina Götze, Dominik Wolf, A.S. Kubasch, Friedrich Stölzel, Malte von Bonin, Mathias Hänel, Hubert Serve, Michael Kramer, Martin Bornhäuser, Alwin Krämer, Regina Herbst, Uta Oelschlägel, Uwe Platzbecker, Jan Moritz Middeke, Katja Sockel, Christoph Groth, Tilmann Bochtler, Anke Mütherig
Publikováno v:
The Lancet Oncology. 19:1668-1679
Summary Background Monitoring of measurable residual disease (MRD) in patients with advanced myelodysplastic syndromes (MDS) or acute myeloid leukaemia (AML) who achieve a morphological complete remission can predict haematological relapse. In this p
Autor:
Marika Mende, Malte von Bonin, Antje Schubert, Anne Kubasch, Richard Noppeney, Marion Subklewe, Sabine Kayser, Friedrich Stoelzel, Michael Kramer, Gesine Bug, Johannes Schetelig, Gerhard Ehninger, Sebastian Stasik, Schumacher Martin, Christian Thiede, Jan-Henrik Mikesch, Juergen Novotny, Katharina Götze, Mathias Haenel, Anke Mütherig, Alwin Krämer, Dominik Wolf, Regina Herbst, Karsten Spiekermann, Lars Fransecky, Tilmann Bochtler, Uwe Platzbecker, Christoph Röllig, Carsten Müller-Tidow, Jan Moritz Middeke, Katja Sockel, Matthias Stelljes, Hubert Serve, Claudia D. Baldus, Ulrich Duehrsen, Martin Bornhäuser
Publikováno v:
Blood. 136:10-11
Background: Monitoring of measurable residual disease (MRD) in patients (pts) with advanced myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) who achieve complete remission (CR) can predict hematological relapse. Recently published data
Autor:
Marika Mende, Katja Sockel
Publikováno v:
The New England journal of medicine. 379(24)
Parvovirus B19 Infection A 67-year-old woman with a history of a lung transplantation presented with dyspnea on exertion and a hemoglobin level of 6.7 g per deciliter. Bone marrow aspiration revealed giant proerythroblasts. PCR testing confirmed parv
Autor:
Sven Nilsson, Juergen Weitz, Mathias Kleiss, Claus-Henning Köhne, Michael Ghadimi, Wolf O. Bechstein, Gunnar Folprecht, Manfred Glados, Volker Kunzmann, Ulf P. Neumann, Ursula Pession, Achim Troja, Ulrike Ubbelohde, Alexander Koenig, Marika Mende, Alexander Stein, Torsten Liersch
Publikováno v:
Journal of Clinical Oncology. 38:4024-4024
4024 Background: EGFR based combinations and the triplet combination FOLFOXIRI are known to increase response rates compared to doublet combinations. Methods: Patients with colorectal cancer and non-resectable liver metastases were enrolled into the
Autor:
Carsten Müller-Tidow, Christoph Röllig, Juergen Novotny, Hubert Serve, Claudia D. Baldus, Karsten Spiekermann, Richard Noppeney, Matthias Stelljes, Uwe Platzbecker, Marika Mende, Ulrich Dührsen, Jan Moritz Middeke, Katja Sockel, Christian Thiede, Schumacher Martin, Katharina Götze, Michael Kramer, Gerhard Ehninger, Mathias Hänel, Anne Sophie Kubasch, Johannes Schetelig, Antje Schubert, Christoph Groth, Lars R. Fransecky, Martin Bornhäuser, Marion Subklewe, Alwin Krämer, Anke Mütherig, Regina Herbst, Tilmann Bochtler, Gesine Bug, Dominik Wolf
Publikováno v:
Blood. 134:644-644
Background: Measurable residual disease (MRD) can identify patients (pts) with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) in complete hematological remission (CR) at high risk of relapse even after allogeneic hematopoietic stem ce
Autor:
Ulrike Proske, Frank Kroschinsky, Frank Dietrich, Raphael Teipel, Uwe Platzbecker, Gerhard Ehninger, Marika Mende, Rainer Ordemann
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 21(20)
We read with great interest the article by Deisseroth and colleagues ([1][1]) focusing on the recent global approval of the monoclonal IL6 antibody siltuximab for the treatment of patients with HHV-8-, HIV-negative multicentric Castleman disease (MCD
Publikováno v:
Journal of Clinical Oncology. 33:598-598
598 Background: Individualized therapy based on molecular stratification has become an integrative part in modern targeted treatment approaches. Here, we aimed to assess whether repeated measurements of cfDNA in patients' plasma could indicate tumor
Autor:
Marika Mende, Ulrich Schuler, Gerhard Ehninger, Beate Hornemann, Gunnar Folprecht, Anke Rentsch, Karolin Trautmann
Publikováno v:
BMC Cancer
Background A better understanding of patients’ views on the benefit and burden obtained from palliative chemotherapy would facilitate shared decision making. We evaluated palliative cancer patients’ reported outcomes (PROs) for toxicity and inves